Abstract:Osteopetrosis is an inherited metabolic disease, characterized by increased bone density and narrow marrow cavity. Patients with severe osteopetrosis exhibit abnormal bone brittleness, anemia, and infection complications, which commonly cause death within the first decade of life. Pathologically, osteopetrosis impairs not only the skeletal system, but also the hemopoietic and immune systems during development, while the underlying osteoimmunological mechanisms remain unclear. Osteoclastic mutations are regarded as the major causes of osteopetrosis, while osteoclast non-autonomous theories have been proposed in recent years with unclear underlying mechanisms. Retinoic acid (RA), the metabolite of Vitamin A, is an essential requirement for skeletal and hematopoietic development, through the activation of retinoic acid signaling. RA can relieve osteopetrosis symptoms in some animal models, while its effect on bone health is still controversial and the underlying mechanisms remain unclear. In this study, we constructed an osteoblast-specific inhibitory retinoic acid signaling mouse model and surprisingly found it mimicked the symptoms of osteopetrosis found in clinical cases: dwarfism, increased imperfectly-formed trabecular bone deposition with a reduced marrow cavity, thin cortical bone with a brittle skeleton, and hematopoietic and immune dysfunction. Micro-CT, the three-point bending test, and histological analysis drew a landscape of poor bone quality. Single-cell RNA sequencing (scRNA-seq) of the femur and RNA-seq of osteoblasts uncovered an atlas of pathological skeletal metabolism dysfunction in the mutant mice showing that osteogenesis was impaired in a cell-autonomous manner and osteoclastogenesis was impaired via osteoblast-osteoclast crosstalk. Moreover, scRNA-seq of bone marrow and flow cytometry of peripheral blood, spleen, and bone marrow uncovered pathology in the hematopoietic and immune systems in the mutant mice, mimicking human osteopetrosis. Results showed that hematopoietic progenitors and B lymphocyte differentiation were affected and the osteoblast-dominated cell crosstalk was impaired, which may result from transcriptional impairment of the ligands Pdgfd and Sema4d . In summary, we uncovered previously unreported pathogenesis of osteopetrosis-like disorder in mice with skeletal, hematopoietic, and immune system dysfunction, which was induced by the inhibition of retinoic acid signaling in osteoblasts, and sheds new insights into a potential treatment for osteopetrosis.

Clinical Characteristics of Osteopetrosis in 4 Children

Osteopetrosis in the pediatric patient: what the radiologist needs to know

Infantile osteopetrosis with delayed development, organomegaly and wandering eyes: case report

Oncogenic Osteomalacia in Renal Cell Carcinoma: a Case Report and Literature Review

Malignant osteopetrosis of infancy: A case report

Clinical and molecular characterization of five Chinese patients with autosomal recessive osteopetrosis

The Virulence Gene and Clinical Phenotypes of Osteopetrosis in the Chinese Population: Six Novel Mutations of the CLCN7 Gene in Twelve Osteopetrosis Families

Post-traumatic Osteolysis of Bone

Characterization of A Relatively Malignant Form of Osteopetrosis Caused by A Novel Mutation in the Plekhm1 Gene

Molecular Mechanisms of Craniofacial and Dental Abnormalities in Osteopetrosis

Clinical and genetic diagnosis of autosomal dominant osteopetrosis type II in a Chinese family: A case report

Osteopetrosis-like disorders induced by osteoblast-specific retinoic acid signaling inhibition in mice

Identification of TCIRG1 and CLCN7 Gene Mutations in a Patient with Autosomal Recessive Osteopetrosis

Novel Mutations of CLCN7 Cause Autosomal Dominant Osteopetrosis Type II (ADOII) and Intermediate Autosomal Recessive Osteopetrosis (ARO) in Seven Chinese Families

Progress in the virulence genes of osteopetrosis

Drug-induced osteopetrosis

Clinical Characteristics and Treatment of Osteopetrosis Complicated by Osteomyelitis of the Mandible.

Characterization of Mineral and Bone Metabolism Biomarkers in a Chinese Consanguineous Twin Family with Primary Hypertrophic Osteoarthropathy.

Natural History of Type II Autosomal Dominant Osteopetrosis: A Single Center Retrospective Study

Alterations in Hematopoietic and Mesenchymal Stromal Cell Components of the Osteopetrotic Bone Marrow Niche

A Novel Compound Heterozygous Mutation of the CLCN7 Gene is Associated with Autosomal Recessive Osteopetrosis